Search Results - "Vaughn, Ivana A."

Refine Results
  1. 1

    Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients by Noureddin, Mazen, Yates, Katherine P., Vaughn, Ivana A., Neuschwander‐Tetri, Brent A., Sanyal, Arun J., McCullough, Arthur, Merriman, Raphael, Hameed, Bilal, Doo, Edward, Kleiner, David E., Behling, Cynthia, Loomba, Rohit

    Published in Hepatology (Baltimore, Md.) (01-11-2013)
    “…The characteristics of nonalcoholic fatty liver disease (NAFLD) in elderly patients are unknown. Therefore, we aimed to examine the differences between elderly…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The Effect of COVID-19 on Mood Disorders in Urban and Suburban Detroit by Yaphe, Sean, Sundaresan, Lakshmi, Freedman, Jonathan D., Weinberg, Samuel J., Vaughn, Ivana A., Lamerato, Lois E., Budzynska, Katarzyna

    Published in AJPM Focus (01-08-2024)
    “…•State of Michigan COVID-19 lockdown began on March 23, 2020.•This is a retrospective study of December 2018–June 2021 administrative data from a large…”
    Get full text
    Journal Article
  4. 4

    Teach-Back Experience and Hospitalization Risk Among Patients with Ambulatory Care Sensitive Conditions: a Matched Cohort Study by Hong, Young-Rock, Cardel, Michelle, Suk, Ryan, Vaughn, Ivana A., Deshmukh, Ashish A., Fisher, Carla L., Pavela, Gregory, Sonawane, Kalyani

    “…Background The teach-back method, also known as the “show-me” method, has been endorsed by many medical and health care societies. However, limited…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators by Marlow, Nicole M., Simpson, Kit N., Vaughn, Ivana A., Jo, Ara, Zoller, James S., Short, Edward B.

    Published in Pain practice (01-02-2018)
    “…Objective To examine medication adherence and healthcare costs for combination prescription initiators (duloxetine/milnacipran/venlafaxine with pregabalin) vs…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Multispecialty Opioid Risk Reduction Program Targeting Chronic Pain and Addiction Management in Veterans by Vaughn, Ivana A, Beyth, Rebecca, Ayers, Mary Lynn, Thornton, Joseph E, Tandon, Rajiv, Gingrich, Ted, Mudra, Stephen A

    Published in Federal practitioner (01-09-2019)
    “…A primary care pain clinic and telehealth program manages veterans at high-risk for noncancer chronic pain and addiction, offering education and support to…”
    Get full text
    Journal Article
  17. 17

    RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older by Surie, Diya, Self, Wesley H, Zhu, Yuwei, Yuengling, Katharine A, Johnson, Cassandra A, Grijalva, Carlos G, Dawood, Fatimah S

    “…This study evaluates the effectiveness of the respiratory syncytial virus vaccine against hospitalization for acute respiratory illness among US adults aged 60…”
    Get full text
    Journal Article
  18. 18

    Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024 by Ma, Kevin C, Surie, Diya, Lauring, Adam S, Martin, Emily T, Leis, Aleda M, Papalambros, Leigh, Gaglani, Manjusha, Columbus, Christie, Gottlieb, Robert L, Ghamande, Shekhar, Peltan, Ithan D, Brown, Samuel M, Ginde, Adit A, Mohr, Nicholas M, Gibbs, Kevin W, Hager, David N, Saeed, Safa, Prekker, Matthew E, Gong, Michelle Ng, Mohamed, Amira, Johnson, Nicholas J, Srinivasan, Vasisht, Steingrub, Jay S, Khan, Akram, Hough, Catherine L, Duggal, Abhijit, Wilson, Jennifer G, Qadir, Nida, Chang, Steven Y, Mallow, Christopher, Kwon, Jennie H, Parikh, Bijal, Exline, Matthew C, Vaughn, Ivana A, Ramesh, Mayur, Safdar, Basmah, Mosier, Jarrod, Harris, Estelle S, Shapiro, Nathan I, Felzer, Jamie, Zhu, Yuwei, Grijalva, Carlos G, Halasa, Natasha, Chappell, James D, Womack, Kelsey N, Rhoads, Jillian P, Baughman, Adrienne, Swan, Sydney A, Johnson, Cassandra A, Rice, Todd W, Casey, Jonathan D, Blair, Paul W, Han, Jin H, Ellington, Sascha, Lewis, Nathaniel M, Thornburg, Natalie, Paden, Clinton R, Atherton, Lydia J, Self, Wesley H, Dawood, Fatimah S, DeCuir, Jennifer

    Published in Clinical infectious diseases (06-08-2024)
    “…Assessing variant-specific COVID-19 vaccine effectiveness (VE) and severity can inform public health risk assessments and decisions about vaccine composition…”
    Get full text
    Journal Article
  19. 19

    Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity—IVY Network, 26 Hospitals, 18 October 2023–9 March 2024 by Ma, Kevin C, Surie, Diya, Lauring, Adam S, Martin, Emily T, Leis, Aleda M, Papalambros, Leigh, Gaglani, Manjusha, Columbus, Christie, Gottlieb, Robert L, Ghamande, Shekhar, Peltan, Ithan D, Brown, Samuel M, Ginde, Adit A, Mohr, Nicholas M, Gibbs, Kevin W, Hager, David N, Saeed, Safa, Prekker, Matthew E, Gong, Michelle Ng, Mohamed, Amira, Johnson, Nicholas J, Srinivasan, Vasisht, Steingrub, Jay S, Khan, Akram, Hough, Catherine L, Duggal, Abhijit, Wilson, Jennifer G, Qadir, Nida, Chang, Steven Y, Mallow, Christopher, Kwon, Jennie H, Parikh, Bijal, Exline, Matthew C, Vaughn, Ivana A, Ramesh, Mayur, Safdar, Basmah, Mosier, Jarrod, Harris, Estelle S, Shapiro, Nathan I, Felzer, Jamie, Zhu, Yuwei, Grijalva, Carlos G, Halasa, Natasha, Chappell, James D, Womack, Kelsey N, Rhoads, Jillian P, Baughman, Adrienne, Swan, Sydney A, Johnson, Cassandra A, Rice, Todd W, Casey, Jonathan D, Blair, Paul W, Han, Jin H, Ellington, Sascha, Lewis, Nathaniel M, Thornburg, Natalie, Paden, Clinton R, Atherton, Lydia J, Self, Wesley H, Dawood, Fatimah S, DeCuir, Jennifer

    Published in Clinical infectious diseases (28-08-2024)
    “…Abstract Background Assessing variant-specific coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) and severity can inform public health risk…”
    Get full text
    Journal Article
  20. 20